The seemingly contradictory coagulation profile observed in MS patients, characterized by shortened APTT alongside reduced Fib and platelet indices, likely reflects a complex dysregulation rather than a simple hyper- or hypocoagulable state. The gene discussed is FBL; the disease is myeloid sarcoma.